Equity reseach Pila Pharma: Sizing up a small molecule in obesity

2026-06-03 13:50:00

Carlsquare Equity Research has published an initial coverage report on Pila Pharma, a biotech developing a pill-based agent for e.g., metabolic diseases, and currently preparing for clinical trials in obesity.

Read the full report here.

About Carlsquare

Carlsquare is a global research firm and financial advisor, focusing on M&A, Equity
Research and Growth Equity. Carlsquare has 150 employees with deep sector knowledge in all 11
GICS sectors. The senior equity research team has extensive experience about the stock
environment and several business sectors. The team produces company research reports,
independent valuations and trading notes. The group have offices in Canada, Denmark, France, Germany, Poland, Sweden, United Kingdom and United States. Read more